Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Kindred Biosciences (KIN)

Kindred Biosciences (KIN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kindred Biosciences 1555 BAYSHORE HIGHWAY SUITE 200 BURLINGAME CA 94010 USA

P: 650-701-7901

Description:

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

Key Statistics

Overview:

Market Capitalization, $K 420,524
Shares Outstanding, K 45,462
Annual Sales, $ 42,160 K
Annual Net Income, $ -21,800 K
Last Quarter Sales, $ 3,540 K
Last Quarter Net Income, $ -9,130 K
60-Month Beta 1.30
% of Insider Shareholders 13.69%
% of Institutional Shareholders 74.07%
Float, K 39,238
% Float 86.31%

Growth:

1-Year Return 134.18%
3-Year Return -37.92%
5-Year Return 120.24%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 59.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/04/21
Earnings Per Share ttm -1.03
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year -130.77%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KIN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -8.92
Price/Earnings to Growth N/A
Return-on-Equity % -54.19%
Return-on-Assets % -39.76%
Profit Margin % -51.71
Net Margin % N/A
Debt/Equity 0.20
Price/Sales 9.97
Price/Cash Flow N/A
Price/Book 5.27
Book Value/Share 1.75
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar